(IN BRIEF) The EIB has signed a €130 million agreement with the Maltese government, marking the first tranche of a €260 million financing package aimed at co-financing key EU-backed projects. The ...

(IN BRIEF) BNP Paribas and the European Investment Bank (EIB) have announced a partnership to inject up to €8 billion into the European wind energy sector. With a €500 million counter-guarantee from ...

SOUTH SAN FRANCISCO - Allogene Therapeutics, Inc. (NASDAQ:ALLO), a biotechnology firm specializing in allogeneic CAR T ...

South Korea's DAAN Biotherapeutics has entered an exclusive deal with LigaChem Biosciences to develop a novel tumor-targeting ...

In its annual results statement, Galapagos chief financial officer Thad Huston said the firm is moving ahead with a planned ...

Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

Golan Heights Displaced Populations: Syrians displaced in the war of 1967 could be financially compensated, and in addition, ...

Allogene Therapeutics Inc (NASDAQ:ALLO). shares have tumbled to a 52-week low, with the stock price touching down at $1.33. According to InvestingPro data, the stock appears undervalued, with analyst ...

The global pharmaceutical water market size was valued at USD 43.36 billion in 2024 and is forecasted to reach around USD 96.25 billion by 2033 with a CAGR of 9.26% from 2024 to 2033.Water is one of ...

AbbVie and Xilio Therapeutics have inked a collaboration and option-to-license agreement potentially worth more than $2 billion to clinical-stage biotechnology company Xilio.

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

HAIFA, Israel (AP) — HAIFA, Israel (AP) — Pluri Inc. (PLUR) on Tuesday reported a loss of $3 million in its fiscal second quarter. On a per-share basis, the Haifa, Israel-based company said it had a ...